(Q46931660)

English

The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analyses

scientific article published in January 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

0 references

The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analyses (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

0 references

author name string

Márcio Machado

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

Michael Iskedjian

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

Inés A Ruiz

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

Thomas R Einarson

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

25

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

11

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

979-990

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

Diagnosis of mental disorder in adults and increased use of health services in four outpatient settings.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725110-00007

21 January 2018

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725110-00007

21 January 2018

Health economic evaluations of antidepressants: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of cost-effective treatments for depression: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Service utilization and social morbidity associated with depressive symptoms in the community.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Guidelines of the Brazilian Medical Association for the treatment of depression (complete version)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression and dysthymia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased use of antidepressants in Canada: 1981-2000.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of cognitive-behavioral therapy for depression: current evidence and future research priorities

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The economic burden of depression in the United States: how did it change between 1990 and 2000?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UK.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic considerations in the prescribing of third-generation antidepressants

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality assessment of published health economic analyses from South America

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brazilian multicentric study of psychiatric morbidity. Methodological features and prevalence estimates

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17960955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200725110-00007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17960955

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46931660&oldid=2208262969"